Quick Takeaways
- Alyeska Investment Group, L.P. filed SCHEDULE 13G for Applied Therapeutics, Inc. Common Stock, par value $0.0001 (APLT).
- Disclosed ownership: 5.8%.
- Date of event: 31 Dec 2024.
Alyeska Investment Group, L.P. - 31 Dec 2024 SCHEDULE 13G Report for Applied Therapeutics, Inc. Common Stock, par value $0.0001 (APLT)
- Filing Manager
- Alyeska Investment Group, L.P.
- Reporting Manager
- Alyeska Investment Group, L.P.
- Symbol
- APLT
- Shares outstanding
- 116,449,601 shares
- Disclosed Ownership
- 6,707,497 shares
- Ownership
- 5.8%
- Form type
- SCHEDULE 13G
- Filing time
- 14 Feb 2025, 16:30:47 UTC
- Date of event
- 31 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Alyeska Investment Group, L.P. disclosed 5.8% ownership in Applied Therapeutics, Inc. Common Stock, par value $0.0001 (APLT) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Feb 2025, 16:30.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Alyeska Investment Group, L.P. | 5.8% | 6,707,497 | 0 | 6,707,497 | Jason Bragg | Jason Bragg | Chief Financial Officer | |
| Alyeska Fund GP, LLC | 5.8% | 6,707,497 | 0 | 6,707,497 | Jason Bragg | Jason Bragg | Chief Financial Officer | |
| Anand Parekh | 5.8% | 6,707,497 | 0 | 6,707,497 | Anand Parekh | Anand Parekh | Self |